Meet the reimagined integrated solution✨ Explore now →
Meet the experts advising DoseMeRx in the pursuit of clinical excellence and governance across Tabula Rasa HealthCare’s Hospital Division.
Professor, Albany College of Pharmacy and Health Sciences
Dr. Lodise is a Professor at Albany College of Pharmacy and Health Sciences in Albany, New York. He received his Doctor of Pharmacy from Temple University School of Pharmacy and his Doctor of Philosophy in Epidemiology from the State University of New York School of Public Health. Integrating his dual interests in scholarship and patient care, Dr. Lodise’s overall research goal is to quantitatively enhance our current understanding of antimicrobial exposure-response relationships in patients with invasive bacterial infections. His research encompasses three interrelated domains: pharmacokinetics (PK)/pharmacodynamics (PD), epidemiology, and outcomes.
Associate Prof. Ernest Mario School of Pharmacy and Rutgers University.
Dr. Brunetti is an Associate Professor at the Ernest Mario School of Pharmacy, Rutgers University and a Clinical Pharmacy Specialist in Internal Medicine at Robert Wood Johnson University Hospital Somerset, New Jersey. He serves as the Co-Director of the Center of Excellence in Pharmaceutical Translational Research and Education (CEPTRE). He received his Doctor of Pharmacy from the Philadelphia College of Pharmacy and a Master of Public Health degree with a concentration in epidemiology at the University of Medicine and Dentistry of New Jersey. His research interests include drug dosing in special populations and the influence of cardiometabolic disease on drug response.
Infectious Diseases Clinical Specialist at Houston Methodist Hospital, Houston.
Dr. Musick is Infectious Diseases Clinical Specialist at Houston Methodist Hospital (HMH) in Houston,TX. He focuses on the Solid-Organ Transplant and Critically Ill populations. He developed and directs the PGY2 Infectious Diseases residency program at HMH and holds adjunct faculty appointments to the University of Houston College of Pharmacy and the University of Texas College of Pharmacy. His professional interests include teaching/training residents and students and researching atypical infections and CMV in the solid-organ transplant population.
Clinical Pharmacy Specialist in Infectious Disease at Houston Methodist Health System
Dr. Patel is System Antimicrobial Stewardship Pharmacy Administrative Specialist at Houston Methodist Health System located in Houston, TX. She is responsible for leading system-wide antimicrobial stewardship, quality improvement, and cost savings initiatives. She received her Doctor of Pharmacy from the University of North Carolina at Chapel Hill and completed her residency training at Vanderbilt University Medical Center in Nashville, TN. Her research interests include improving antibiotic utilization and evaluating the utility of rapid diagnostics and clinical decision support in the clinical setting.
Program Coordinator for Antimicrobial Stewardship at Cedars-Sinai Medical Center, Los Angeles.
Dr. Smith is a Program Coordinator for Antimicrobial Stewardship at Cedars-Sinai Medical Center in Los Angeles, California. He is the PGY-1/PGY-2 residency preceptor for infectious diseases/antimicrobial stewardship. He is also Assistant Clinical Professor of Pharmacy for the University of California San Francisco School of Pharmacy and Adjunct Assistant Professor of Pharmacy Practice for the University of Southern California School of Pharmacy. His research interests include antimicrobial stewardship and more recently clinical and therapeutic treatment options in COVID-19.
Pharmacy Clinical Coordinator, Critical Care, and Infectious Diseases, St. Christopher’s Hospital
Jeff received his Doctor of Pharmacy degree from the Virginia Commonwealth University and his Masters in Public Health from Temple University, with a concentration is Biostatistics and Epidemiology. His research focuses on describing anti-microbial pharmacokinetic and pharmacodynamic changes in critically ill children, children with cystic fibrosis and children with cancer in addition to beta-lactam therapeutic drug management to provide insight regarding appropriate dosing regimens for these vulnerable populations.
Chief Scientific Officer and CEO, TRHC Precision Pharmacotherapy, Research and Development Institute
Dr. Turgeon is the Chief Scientific Officer and CEO of the TRHC Precision Pharmacotherapy Research and Development Institute. Prior to coming to TRHC, he was an Associate Dean and Professor of Pharmaceutics at the University of Florida (UF) College of Pharmacy. He has also held several leadership positions at the University of Montreal. He is a known expert on pharmacogenetics and drug–drug interactions, particularly among treatments for cardiovascular disease.
Senior Director of Pharmacy Solutions for DoseMeRx
Sharmeen is the Sr. Director of Pharmacy Solutions for DoseMeRx. She has spent the majority of her 20-year career within pediatric clinical pharmacy, clinical research, and pharmacogenomics. She is passionate about pediatric critical care and leveraging technology to amplify the impact of the pharmacist. She received her Doctor of Pharmacy degree from the University of Illinois at Chicago and completed a Pediatric Specialty Pharmacotherapy Residency at Texas Children’s Hospital. Sharmeen now resides in Miami, FL.
See how easy DoseMeRx is to operate and integrate into your workday.